Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19—experiences of a longitudinal series of 92 patients

Minimally invasive autopsies (MIAs) allow the collection of tissue samples for diagnostic and research purposes in special situations, e.g., when there is a high risk of infection which is the case in the context of COVID-19 or restrictions due to legal or personal reasons. We performed MIA to analy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virchows Archiv : an international journal of pathology 2023-11, Vol.483 (5), p.611-619
Hauptverfasser: Noack, Petar, Grosse, Claudia, Bodingbauer, Jacob, Almeder, Marion, Lohfink-Schumm, Sylvia, Salzer, Helmut J.F., Meier, Jens, Lamprecht, Bernd, Schmitt, Clemens A., Langer, Rupert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 619
container_issue 5
container_start_page 611
container_title Virchows Archiv : an international journal of pathology
container_volume 483
creator Noack, Petar
Grosse, Claudia
Bodingbauer, Jacob
Almeder, Marion
Lohfink-Schumm, Sylvia
Salzer, Helmut J.F.
Meier, Jens
Lamprecht, Bernd
Schmitt, Clemens A.
Langer, Rupert
description Minimally invasive autopsies (MIAs) allow the collection of tissue samples for diagnostic and research purposes in special situations, e.g., when there is a high risk of infection which is the case in the context of COVID-19 or restrictions due to legal or personal reasons. We performed MIA to analyze lung tissue from 92 COVID-19 patients (mean age 78 years; range 48–98; 35 women, 57 men), representing 44% of all patients who died from the disease between October 2020 and April 2021. An intercostal approach was used with removal of a 5-cm rib section followed by manual collection of four lung tissue samples (5–8 cm in size). Diffuse alveolar damage (DAD) was found in 89 (97%) patients at various stages. Exudative DAD (eDAD) predominated in 18 (20%) patients, proliferative DAD (pDAD) in 43 (47%) patients, and mixed DAD (mDAD) in 31 (34%) patients. There were no significant differences in the predominant DAD pattern between tissue samples from the same patient. Additional purulent components were present in 46 (50%) cases. Fungi were detected in 11 (12%) patients. The pDAD pattern was associated with longer hospital stay including intensive care unit ( p =0.026 and p
doi_str_mv 10.1007/s00428-023-03622-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2860406769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2860406769</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-62707b576cd2a96d4312e3d2a87fabe587ecfc0904ebcd5d821f80e2fa5613c73</originalsourceid><addsrcrecordid>eNp9kb1uFDEUhS0EEkvgBags0dCYXF_P2DMlWv4iBaUBWsvr8Wwcee3BnomyHT0tT8iTxJNFQqKgutY93znS9SHkJYc3HECdF4AGOwYoGAiJyOQjsuGNQIYC1GOygb5pmRRcPSXPSrkBQN5xuSE_P_voDyaEI_Xx1hR_66hZ5jQV7wodU6bztVslV2a_N7NPkaaRTks4pGjykU5mvk4h7Y_renv17eId4_3vH7_c3eSyd9HWmKoYGlLc-3kZfDSBllV7EHpcIyo4l-fkyWhCcS_-zDPy9cP7L9tP7PLq48X27SWzolEzk6hA7Vol7YCml0MjODpR350azc61nXJ2tNBD43Z2aIcO-diBw9G0kgurxBl5fcqdcvq-1MP0wRfrQjDRpaVo7CQ0IJXsK_rqH_QmLblesFK9QNk2HVYKT5TNqZTsRj3l-qn5qDnotR996kfXfvRDP1pWkziZSoXj3uW_0f9x3QPKo5XL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2893265482</pqid></control><display><type>article</type><title>Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19—experiences of a longitudinal series of 92 patients</title><source>Springer Nature - Complete Springer Journals</source><creator>Noack, Petar ; Grosse, Claudia ; Bodingbauer, Jacob ; Almeder, Marion ; Lohfink-Schumm, Sylvia ; Salzer, Helmut J.F. ; Meier, Jens ; Lamprecht, Bernd ; Schmitt, Clemens A. ; Langer, Rupert</creator><creatorcontrib>Noack, Petar ; Grosse, Claudia ; Bodingbauer, Jacob ; Almeder, Marion ; Lohfink-Schumm, Sylvia ; Salzer, Helmut J.F. ; Meier, Jens ; Lamprecht, Bernd ; Schmitt, Clemens A. ; Langer, Rupert</creatorcontrib><description>Minimally invasive autopsies (MIAs) allow the collection of tissue samples for diagnostic and research purposes in special situations, e.g., when there is a high risk of infection which is the case in the context of COVID-19 or restrictions due to legal or personal reasons. We performed MIA to analyze lung tissue from 92 COVID-19 patients (mean age 78 years; range 48–98; 35 women, 57 men), representing 44% of all patients who died from the disease between October 2020 and April 2021. An intercostal approach was used with removal of a 5-cm rib section followed by manual collection of four lung tissue samples (5–8 cm in size). Diffuse alveolar damage (DAD) was found in 89 (97%) patients at various stages. Exudative DAD (eDAD) predominated in 18 (20%) patients, proliferative DAD (pDAD) in 43 (47%) patients, and mixed DAD (mDAD) in 31 (34%) patients. There were no significant differences in the predominant DAD pattern between tissue samples from the same patient. Additional purulent components were present in 46 (50%) cases. Fungi were detected in 11 (12%) patients. The pDAD pattern was associated with longer hospital stay including intensive care unit ( p =0.026 and p &lt;0.001) and younger age ( p =0.019). Positive bronchoalveolar lavage and blood cultures were observed more frequently in pDAD patterns ( p &lt;0.001; p =0.018). In contrast, there was no significant association between intravital positive microbiological results and superimposed bronchopneumonia or fungal infection at autopsy. Having demonstrated the characteristic lung changes in a large longitudinal autopsy series, we conclude that the presented MIA approach can be considered a reliable and safe method for performing post mortem lung diagnostics in COVID-19 and other high-risk situations. The lack of correlation between histological changes indicative of bacterial or fungal superinfection and microbiology could have clinical implications for disease and treatment surveillance.</description><identifier>ISSN: 0945-6317</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s00428-023-03622-6</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Alveoli ; Autopsies ; Autopsy ; Bronchopneumonia ; Bronchus ; COVID-19 ; Exudation ; Fatalities ; Fungi ; Health risks ; Lavage ; Lungs ; Medicine ; Medicine &amp; Public Health ; Microbiology ; Original Article ; Pathology ; Patients ; Superinfection ; Viral diseases</subject><ispartof>Virchows Archiv : an international journal of pathology, 2023-11, Vol.483 (5), p.611-619</ispartof><rights>The Author(s) 2023</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c347t-62707b576cd2a96d4312e3d2a87fabe587ecfc0904ebcd5d821f80e2fa5613c73</cites><orcidid>0000-0001-9491-3609</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00428-023-03622-6$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00428-023-03622-6$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Noack, Petar</creatorcontrib><creatorcontrib>Grosse, Claudia</creatorcontrib><creatorcontrib>Bodingbauer, Jacob</creatorcontrib><creatorcontrib>Almeder, Marion</creatorcontrib><creatorcontrib>Lohfink-Schumm, Sylvia</creatorcontrib><creatorcontrib>Salzer, Helmut J.F.</creatorcontrib><creatorcontrib>Meier, Jens</creatorcontrib><creatorcontrib>Lamprecht, Bernd</creatorcontrib><creatorcontrib>Schmitt, Clemens A.</creatorcontrib><creatorcontrib>Langer, Rupert</creatorcontrib><title>Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19—experiences of a longitudinal series of 92 patients</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><description>Minimally invasive autopsies (MIAs) allow the collection of tissue samples for diagnostic and research purposes in special situations, e.g., when there is a high risk of infection which is the case in the context of COVID-19 or restrictions due to legal or personal reasons. We performed MIA to analyze lung tissue from 92 COVID-19 patients (mean age 78 years; range 48–98; 35 women, 57 men), representing 44% of all patients who died from the disease between October 2020 and April 2021. An intercostal approach was used with removal of a 5-cm rib section followed by manual collection of four lung tissue samples (5–8 cm in size). Diffuse alveolar damage (DAD) was found in 89 (97%) patients at various stages. Exudative DAD (eDAD) predominated in 18 (20%) patients, proliferative DAD (pDAD) in 43 (47%) patients, and mixed DAD (mDAD) in 31 (34%) patients. There were no significant differences in the predominant DAD pattern between tissue samples from the same patient. Additional purulent components were present in 46 (50%) cases. Fungi were detected in 11 (12%) patients. The pDAD pattern was associated with longer hospital stay including intensive care unit ( p =0.026 and p &lt;0.001) and younger age ( p =0.019). Positive bronchoalveolar lavage and blood cultures were observed more frequently in pDAD patterns ( p &lt;0.001; p =0.018). In contrast, there was no significant association between intravital positive microbiological results and superimposed bronchopneumonia or fungal infection at autopsy. Having demonstrated the characteristic lung changes in a large longitudinal autopsy series, we conclude that the presented MIA approach can be considered a reliable and safe method for performing post mortem lung diagnostics in COVID-19 and other high-risk situations. The lack of correlation between histological changes indicative of bacterial or fungal superinfection and microbiology could have clinical implications for disease and treatment surveillance.</description><subject>Alveoli</subject><subject>Autopsies</subject><subject>Autopsy</subject><subject>Bronchopneumonia</subject><subject>Bronchus</subject><subject>COVID-19</subject><subject>Exudation</subject><subject>Fatalities</subject><subject>Fungi</subject><subject>Health risks</subject><subject>Lavage</subject><subject>Lungs</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Microbiology</subject><subject>Original Article</subject><subject>Pathology</subject><subject>Patients</subject><subject>Superinfection</subject><subject>Viral diseases</subject><issn>0945-6317</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kb1uFDEUhS0EEkvgBags0dCYXF_P2DMlWv4iBaUBWsvr8Wwcee3BnomyHT0tT8iTxJNFQqKgutY93znS9SHkJYc3HECdF4AGOwYoGAiJyOQjsuGNQIYC1GOygb5pmRRcPSXPSrkBQN5xuSE_P_voDyaEI_Xx1hR_66hZ5jQV7wodU6bztVslV2a_N7NPkaaRTks4pGjykU5mvk4h7Y_renv17eId4_3vH7_c3eSyd9HWmKoYGlLc-3kZfDSBllV7EHpcIyo4l-fkyWhCcS_-zDPy9cP7L9tP7PLq48X27SWzolEzk6hA7Vol7YCml0MjODpR350azc61nXJ2tNBD43Z2aIcO-diBw9G0kgurxBl5fcqdcvq-1MP0wRfrQjDRpaVo7CQ0IJXsK_rqH_QmLblesFK9QNk2HVYKT5TNqZTsRj3l-qn5qDnotR996kfXfvRDP1pWkziZSoXj3uW_0f9x3QPKo5XL</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Noack, Petar</creator><creator>Grosse, Claudia</creator><creator>Bodingbauer, Jacob</creator><creator>Almeder, Marion</creator><creator>Lohfink-Schumm, Sylvia</creator><creator>Salzer, Helmut J.F.</creator><creator>Meier, Jens</creator><creator>Lamprecht, Bernd</creator><creator>Schmitt, Clemens A.</creator><creator>Langer, Rupert</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9491-3609</orcidid></search><sort><creationdate>20231101</creationdate><title>Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19—experiences of a longitudinal series of 92 patients</title><author>Noack, Petar ; Grosse, Claudia ; Bodingbauer, Jacob ; Almeder, Marion ; Lohfink-Schumm, Sylvia ; Salzer, Helmut J.F. ; Meier, Jens ; Lamprecht, Bernd ; Schmitt, Clemens A. ; Langer, Rupert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-62707b576cd2a96d4312e3d2a87fabe587ecfc0904ebcd5d821f80e2fa5613c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alveoli</topic><topic>Autopsies</topic><topic>Autopsy</topic><topic>Bronchopneumonia</topic><topic>Bronchus</topic><topic>COVID-19</topic><topic>Exudation</topic><topic>Fatalities</topic><topic>Fungi</topic><topic>Health risks</topic><topic>Lavage</topic><topic>Lungs</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Microbiology</topic><topic>Original Article</topic><topic>Pathology</topic><topic>Patients</topic><topic>Superinfection</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noack, Petar</creatorcontrib><creatorcontrib>Grosse, Claudia</creatorcontrib><creatorcontrib>Bodingbauer, Jacob</creatorcontrib><creatorcontrib>Almeder, Marion</creatorcontrib><creatorcontrib>Lohfink-Schumm, Sylvia</creatorcontrib><creatorcontrib>Salzer, Helmut J.F.</creatorcontrib><creatorcontrib>Meier, Jens</creatorcontrib><creatorcontrib>Lamprecht, Bernd</creatorcontrib><creatorcontrib>Schmitt, Clemens A.</creatorcontrib><creatorcontrib>Langer, Rupert</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noack, Petar</au><au>Grosse, Claudia</au><au>Bodingbauer, Jacob</au><au>Almeder, Marion</au><au>Lohfink-Schumm, Sylvia</au><au>Salzer, Helmut J.F.</au><au>Meier, Jens</au><au>Lamprecht, Bernd</au><au>Schmitt, Clemens A.</au><au>Langer, Rupert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19—experiences of a longitudinal series of 92 patients</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><stitle>Virchows Arch</stitle><date>2023-11-01</date><risdate>2023</risdate><volume>483</volume><issue>5</issue><spage>611</spage><epage>619</epage><pages>611-619</pages><issn>0945-6317</issn><eissn>1432-2307</eissn><abstract>Minimally invasive autopsies (MIAs) allow the collection of tissue samples for diagnostic and research purposes in special situations, e.g., when there is a high risk of infection which is the case in the context of COVID-19 or restrictions due to legal or personal reasons. We performed MIA to analyze lung tissue from 92 COVID-19 patients (mean age 78 years; range 48–98; 35 women, 57 men), representing 44% of all patients who died from the disease between October 2020 and April 2021. An intercostal approach was used with removal of a 5-cm rib section followed by manual collection of four lung tissue samples (5–8 cm in size). Diffuse alveolar damage (DAD) was found in 89 (97%) patients at various stages. Exudative DAD (eDAD) predominated in 18 (20%) patients, proliferative DAD (pDAD) in 43 (47%) patients, and mixed DAD (mDAD) in 31 (34%) patients. There were no significant differences in the predominant DAD pattern between tissue samples from the same patient. Additional purulent components were present in 46 (50%) cases. Fungi were detected in 11 (12%) patients. The pDAD pattern was associated with longer hospital stay including intensive care unit ( p =0.026 and p &lt;0.001) and younger age ( p =0.019). Positive bronchoalveolar lavage and blood cultures were observed more frequently in pDAD patterns ( p &lt;0.001; p =0.018). In contrast, there was no significant association between intravital positive microbiological results and superimposed bronchopneumonia or fungal infection at autopsy. Having demonstrated the characteristic lung changes in a large longitudinal autopsy series, we conclude that the presented MIA approach can be considered a reliable and safe method for performing post mortem lung diagnostics in COVID-19 and other high-risk situations. The lack of correlation between histological changes indicative of bacterial or fungal superinfection and microbiology could have clinical implications for disease and treatment surveillance.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s00428-023-03622-6</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-9491-3609</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0945-6317
ispartof Virchows Archiv : an international journal of pathology, 2023-11, Vol.483 (5), p.611-619
issn 0945-6317
1432-2307
language eng
recordid cdi_proquest_miscellaneous_2860406769
source Springer Nature - Complete Springer Journals
subjects Alveoli
Autopsies
Autopsy
Bronchopneumonia
Bronchus
COVID-19
Exudation
Fatalities
Fungi
Health risks
Lavage
Lungs
Medicine
Medicine & Public Health
Microbiology
Original Article
Pathology
Patients
Superinfection
Viral diseases
title Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19—experiences of a longitudinal series of 92 patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T17%3A20%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minimally%20invasive%20autopsies%20for%20the%20investigation%20of%20pulmonary%20pathology%20of%20COVID-19%E2%80%94experiences%20of%20a%20longitudinal%20series%20of%2092%20patients&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=Noack,%20Petar&rft.date=2023-11-01&rft.volume=483&rft.issue=5&rft.spage=611&rft.epage=619&rft.pages=611-619&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s00428-023-03622-6&rft_dat=%3Cproquest_cross%3E2860406769%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2893265482&rft_id=info:pmid/&rfr_iscdi=true